ranging from interactions with circulating immune cells to pathogenesis of liver fibrosis. Obviously, this sinusoidal tissue unit is not correctly recapitulated by the currently available artificial microtissues. Similar critical limitations could be described for microtissues representing other organs. In conclusion, microfluidics offer the prospect to establish complex physiological scenarios under accurately 'reproducible in vitro conditions'. However, the hunt for a 'body-on-a-chip' or even an 'organ-on-a-chip' that really deserves this name has only just begun. 
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